<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604483</url>
  </required_header>
  <id_info>
    <org_study_id>PTNS for anal fissure</org_study_id>
    <nct_id>NCT04604483</nct_id>
  </id_info>
  <brief_title>Percutaneous Tibial Nerve Stimulation (PTNS) for the Treatment of Chronic Anal Fissure</brief_title>
  <official_title>Percutaneous Tibial Nerve Stimulation for Chronic Anal Fissure - a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic anal fissure rarely heals spontaneously. About 50% heal on administration om topical&#xD;
      muscle relaxants (e.g. diltiazem) and/or injection of Botulinum toxin, but for the remainder&#xD;
      of patients surgery (with lateral internal sphincterotomy or fissurectomy) with subsequent&#xD;
      risks of anal incontinence has been the golden standard. Treatment with PTNS (percutaneous&#xD;
      tibial nerve stimulation) has been showed to produce healing of chronic anal fissures not&#xD;
      responding to topical treatment, thus avoiding the risk for debilitating anal incontinence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will prospectively include 52 patients with chronic anal fissure that have&#xD;
      received topical treatment and stool softeners and have all been evaluated by experienced&#xD;
      proctological surgeons. The treatment will be given for 10 consecutive work days and then&#xD;
      evaluated at 3 and 12 months. If the patients symptoms are unimproved at 3 months alternative&#xD;
      treatments will be offered.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective non-randomized trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing rate</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Healing of anal fissure from assessement of clinical and/or data from patient form</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Healing rate</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Healing of anal fissure from assessement of clinical and/or data from patient form</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bowel movements</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Changes in frequency of bowel emptying and consistency of bowel contents Before and after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel movements</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Changes in frequency of bowel emptying and consistency of bowel contents Before and after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Reports of adverse effects (subjective/objective)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Reports of adverse effects (subjective/objective)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Differences in healing rates between smokers and non-smokers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking</measure>
    <time_frame>12 months after treatment</time_frame>
    <description>Differences in healing rates between smokers and non-smokers</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Fissure in Ano</condition>
  <arm_group>
    <arm_group_label>PTNS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with PTNS for chronic anal fissure, treatment to be given for 30 minutes during 10 consecutive work Days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PTNS</intervention_name>
    <description>Patients meeting the criteria are treated with PTNS and are evaluated at 3 months and 1 year after end of treatment.</description>
    <arm_group_label>PTNS</arm_group_label>
    <other_name>Percutaneous Tibial Nerve Stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified anal fissure (Clinical assessement by experienced proctological surgeon)&#xD;
&#xD;
          -  Full conservative treatment has been given&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
&#xD;
          -  Fistula and/or anal abscess&#xD;
&#xD;
          -  Patients with compromised immunity&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Treatment with anti-coagulants (not aspirin)&#xD;
&#xD;
          -  Previous irradiation towards pelvic floor&#xD;
&#xD;
          -  Pacemaker or implanted defibrillator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis B Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Lindsten, MD</last_name>
    <phone>+4640331000</phone>
    <email>martin.lindsten@skane.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Strandberg</last_name>
    <phone>+4640331000</phone>
    <email>sara.strandberg@skane.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sk√•ne University Hospital</name>
      <address>
        <city>Malmo</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003431. doi: 10.1002/14651858.CD003431.pub3. Review.</citation>
    <PMID>22336789</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anal fissure</keyword>
  <keyword>Percutaneous Tibial Nerve Stimulation</keyword>
  <keyword>PTNS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fissure in Ano</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No intention to make individual participant data available to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

